DWA
CL icon

Douglass Winthrop Advisors’s Colgate-Palmolive CL Stock Holding History

Douglass Winthrop Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$567K Sell
6,653
-350
-5% -$31.2K 0.01% 205
2025
Q4 		$553K Hold
7,003
– – 0.01% 207
2025
Q3 		$560K Buy
7,003
+800
+13% +$68.2K 0.01% 195
2025
Q2 		$564K Sell
6,203
-450
-7% -$41.1K 0.01% 185
2025
Q1 		$623K Sell
6,653
-768
-10% -$68.8K 0.01% 174
2024
Q4 		$675K Buy
7,421
+400
+6% +$38.2K 0.01% 174
2024
Q3 		$729K Hold
7,021
– – 0.01% 175
2024
Q2 		$681K Sell
7,021
-362
-5% -$33.4K 0.01% 166
2024
Q1 		$665K Hold
7,383
– – 0.01% 170
2023
Q4 		$588K Hold
7,383
– – 0.01% 161
2023
Q3 		$525K Buy
7,383
+605
+9% +$45.2K 0.01% 157
2023
Q2 		$522K Sell
6,778
-100
-1% -$7.74K 0.01% 166
2023
Q1 		$517K Sell
6,878
-1,900
-22% -$141K 0.01% 168
2022
Q4 		$692K Hold
8,778
– – 0.02% 146
2022
Q3 		$617K Sell
8,778
-100
-1% -$7.84K 0.02% 143
2022
Q2 		$711K Sell
8,878
-600
-6% -$46.9K 0.02% 140
2022
Q1 		$719K Sell
9,478
-250
-3% -$19.8K 0.02% 155
2021
Q4 		$830K Sell
9,728
-2,681
-22% -$209K 0.02% 151
2021
Q3 		$938K Buy
12,409
+1,075
+9% +$85.4K 0.02% 140
2021
Q2 		$922K Buy
11,334
+306
+3% +$25K 0.02% 145
2021
Q1 		$869K Buy
11,028
+1,600
+17% +$125K 0.02% 148
2020
Q4 		$806K Buy
9,428
+72
+0.8% +$5.95K 0.02% 144
2020
Q3 		$722K Buy
9,356
+1,698
+22% +$129K 0.02% 141
2020
Q2 		$561K Buy
7,658
+100
+1% +$7.1K 0.02% 149
2020
Q1 		$502K Sell
7,558
-2,434
-24% -$172K 0.02% 149
2019
Q4 		$688K Sell
9,992
-2,150
-18% -$147K 0.02% 157
2019
Q3 		$893K Buy
12,142
+1,674
+16% +$121K 0.03% 127
2019
Q2 		$750K Sell
10,468
-225
-2% -$16K 0.03% 145
2019
Q1 		$733K Sell
10,693
-543,709
-98% -$35.1M 0.03% 133
2018
Q4 		$33M Sell
554,402
-6,748
-1% -$422K 1.64% 26
2018
Q3 		$37.6M Buy
561,150
+16,702
+3% +$1.11M 1.66% 24
2018
Q2 		$35.3M Buy
544,448
+13,876
+3% +$908K 1.59% 23
2018
Q1 		$38M Buy
530,572
+33,517
+7% +$2.41M 1.85% 18
2017
Q4 		$37.5M Buy
497,055
+8,349
+2% +$610K 2.04% 19
2017
Q3 		$35.6M Buy
488,706
+5,180
+1% +$373K 2.07% 21
2017
Q2 		$35.8M Buy
483,526
+4,426
+0.9% +$329K 2.17% 19
2017
Q1 		$35.1M Buy
479,100
+85
+0% +$5.95K 2.19% 14
2016
Q4 		$31.3M Buy
479,015
+33,763
+8% +$2.31M 2.12% 18
2016
Q3 		$33M Sell
445,252
-2,944
-0.7% -$218K 2.28% 13
2016
Q2 		$32.8M Sell
448,196
-11,740
-3% -$836K 2.31% 11
2016
Q1 		$32.5M Sell
459,936
-9,295
-2% -$618K 2.34% 10
2015
Q4 		$31.3M Buy
469,231
+12,904
+3% +$858K 2.32% 12
2015
Q3 		$29M Buy
456,327
+29,703
+7% +$1.94M 2.28% 11
2015
Q2 		$29.6M Hold
426,624
– – 2.3% 14
2015
Q1 		$29.6M Buy
426,624
+41,565
+11% +$2.87M 2.3% 14
2014
Q4 		$26.6M Buy
385,059
+7,417
+2% +$501K 2.38% 16
2014
Q3 		$24.6M Buy
377,642
+13,750
+4% +$907K 2.27% 17
2014
Q2 		$24.8M Buy
363,892
+1,470
+0.4% +$98.5K 2.28% 18
2014
Q1 		$23.5M Buy
362,422
+12,252
+3% +$772K 2.32% 16
2013
Q4 		$22.8M Buy
350,170
+14,040
+4% +$899K 2.37% 15
2013
Q3 		$19.9M Buy
336,130
+14,500
+5% +$859K 2.31% 17
2013
Q2 		$18.4M Buy
+321,630
New +$19.1M 2.23% 18

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Douglass Winthrop Advisors's CL Position: Q1 2026 in Review

Douglass Winthrop Advisors reduced its Colgate-Palmolive (CL) stake by 5% in Q1 2026, selling an estimated $31.2K and leaving 6,653 shares worth $567K. The position accounts for 0.01% of the portfolio, ranked #205.

Douglass Winthrop Advisors first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $38M in Q1 2018. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Douglass Winthrop Advisors held 6,653 shares of Colgate-Palmolive worth $567K as of Q1 2026.
  • Douglass Winthrop Advisors sold 350 Colgate-Palmolive shares in Q1 2026, an estimated $31.2K.
  • Colgate-Palmolive made up 0.01% of Douglass Winthrop Advisors's portfolio in Q1 2026, its #205 holding.
  • Douglass Winthrop Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Douglass Winthrop Advisors's Colgate-Palmolive position peaked at $38M in Q1 2018.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Douglass Winthrop Advisors's 13F filing for Q1 2026, filed 14 May 2026.